ArticleCureus2026
A Presentation of Meckel's Diverticulum With Malignancy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMeckel's diverticulum (MD) is the most common congenital gastrointestinal anomaly resulting from incomplete obliteration of the omphalomesenteric duct. Although often asymptomatic, MD may rarely harbor malignancies. The management of incidentally discovered MD in adults remains controversial. CASE PRESENTATION: A man in his 70s presented with abdominal pain and iron deficiency anemia. Computed tomography demonstrated a 13 × 14 cm heterogeneously enhancing right lower quadrant mass concerning for a primary mesenteric neoplasm. The patient underwent surgical resection, and intraoperative findings revealed a large mass arising from a previously undiagnosed MD. En bloc segmental small bowel resection with associated mesentery was performed. Postoperative recovery was notable for transient ileus. Final pathology demonstrated high-grade undifferentiated carcinoma. Molecular profiling revealed high microsatellite instability (MSI-H) status, programmed death-ligand 1 (PD-L1) positivity, high tumor mutational burden, and an ATM mutation, guiding initiation of immunotherapy. DISCUSSION: Neoplasms in MD are rare and most commonly neuroendocrine in origin; undifferentiated carcinoma is exceedingly uncommon. This case highlights the diagnostic challenge of MD presenting as a large mesenteric mass and underscores the importance of molecular profiling in identifying actionable biomarkers, particularly in rare malignancies lacking established treatment guidelines. Contemporary evidence supports a selective approach to incidental MD resection, with risk stratification based on factors such as age, sex, and diverticulum size.
conclusionUndifferentiated carcinoma should be considered in the differential diagnosis of large mesenteric masses. This case emphasizes the importance of recognizing atypical presentations of MD and the critical role of molecular characterization in guiding personalized therapy when conventional management strategies are limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.